← Back to Search

Behavioural Intervention

Personalized Treatment for Eating Disorders (T-NIPT-ED Trial)

N/A

Recruiting

Led By Cheri A Levinson, PhD

Research Sponsored by University of Louisville

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Current diagnosis of any active eating disorder except ARFID

Ages 18-65

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 18 weeks

Awards & highlights

No Placebo-Only Group

Summary

This trial aims to develop a personalized treatment for eating disorders (EDs) by considering individual factors and social context. Current treatments for EDs have limited success, and there is a need for more effective

Who is the study for?

This trial is for adults aged 18-65 with an active eating disorder, excluding ARFID. It's not suitable for individuals who are currently experiencing suicidal thoughts, mania, or psychosis.

What is being tested?

The study compares a new personalized treatment (T-NIPT-ED) using mobile technology and individual modeling to the standard Cognitive Behavioral Therapy Enhanced (CBT-E) in treating eating disorders.

What are the potential side effects?

Since this trial involves therapy rather than medication, side effects may include emotional discomfort or distress due to discussing personal issues during sessions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have an active eating disorder, but it's not ARFID.

Select...

I am between 18 and 65 years old.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 18 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 18 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 18 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Clinical impairment

Eating disorder symptoms

Secondary study objectives

Health service utilization using the Health Utilization and Medical Comorbidities

Medical comorbidities using the Health Utilization and Medical Comorbidities

Psychological comorbidities using Structured Clinical Interview for DSM-5 (SCID-5)

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Transdiagnostic Network Informed Personalized TreatmentExperimental Treatment1 Intervention

Participants will receive 1 session of education about the treatment after completing Phase I of the study (two weeks of ecological momentary assessment). Participants will then complete 10 sessions of personalized treatment for eating disorders based on their ecological momentary assessment surveys. Participants will complete one session of relapse prevention at the end.

Group II: Cognitive Behavioral Therapy for Eating DisordersActive Control1 Intervention

Participants will receive 1 session of education about the treatment after completing Phase I of the study (two weeks of ecological momentary assessment). Participants will then complete 10 sessions of Enhanced Cognitive Behavioral Therapy for Eating Disorders (CBT-E. Participants will complete one session of relapse prevention at the end.

0 / 2Eligibility criteria met